Citation Impact
Citing Papers
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia
2013
Heparin-Protein Interactions
2002 Standout
Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia
2006
Cellular microparticles: new players in the field of vascular disease?
2004
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia
2013
Regulation of cell death: the calcium–apoptosis link
2003 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients
2003
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia
1996
Antithrombotic Therapy for VTE Disease
2016 Standout
Heparin-Induced Thrombocytopenia
1998
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
2003
Antiphospholipid Syndrome and Heparin-induced Thrombocytopenia: Update on Similarities and Differences
2000
Cell Membrane Microparticles in Blood and Blood Products: Potentially Pathogenic Agents and Diagnostic Markers
2005
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
1999
Soluble P‐selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome
1993
Antithrombotic Therapy for VTE Disease
2012 Standout
Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis
2005
Heparin-Induced Thrombocytopenia
2006 Standout
The Antiphospholipid Syndrome
2002 Standout
Original Article: Evaluation of Platelet Function by Flow Cytometric Measurement of Ligand Binding
1995 StandoutNobel
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation
2005
HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE EFFECTS OF HEPARIN THERAPY
1998
Platelets and the immune continuum
2011 Standout
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
How were new medicines discovered?
2011 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2012
Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy
2000
A 14-year study of heparin-induced thrombocytopenia
1996 Standout
Safety of Warfarin Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Prevention of Venous Thromboembolism
2008 Standout
The Pathophysiology of Heparin-Induced Thrombocytopenia
2005
Complement-Independent, Peroxide-Induced Antibody Lysis of Platelets in HIV-1-Related Immune Thrombocytopenia
2001
Disseminated Intravascular Coagulation
1999 Standout
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia
1999
Recurrent miscarriage
2006 Standout
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Heparin-induced Thrombocytopenia, a Prothrombotic Disease
2007
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
Alterations in Bcl‐2/Bax protein levels in platelets form part of an ionomycin‐induced process that resembles apoptosis
1997
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
2001
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
1998
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Platelet-derived microparticles associate with fibrin during thrombosis
1996
Heparin-induced Thrombocytopenia: Towards Consensus
1998
Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies
2004
Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Endotoxin induced platelet microvesicle formation measured by flow cytometry
1996 StandoutNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
State-of-the-Art Review : Heparin-induced Thrombocytopenia and Thrombosis Syndrome
1998
FcγRIIA H/R131 Polymorphism, Subclass-Specific IgG Anti-Heparin/Platelet Factor 4 Antibodies and Clinical Course in Patients With Heparin-Induced Thrombocytopenia and Thrombosis
1997
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
1999 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Circulating Procoagulant Microparticles in Women with Unexplained Pregnancy Loss: a New Insight
2001
Alteration of Marrow Cell Gene Expression, Protein Production, and Engraftment into Lung by Lung-Derived Microvesicles: A Novel Mechanism for Phenotype Modulation
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Low-Molecular-Weight Heparins
1997 Standout
Cell-Derived Microparticles Generated in Patients During Cardiopulmonary Bypass Are Highly Procoagulant
1997
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis
2000
Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG/serum and other IgG platelet agonists: a comparison with standard platelet agonists
1999
Endothelial Function and Dysfunction
2007 Standout
Works of AP Bode being referenced
Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia
1994
Platelet activation may explain the storage lesion in platelet concentrates.
1990
Vesiculation of platelets during in vitro aging
1991